Waldenström Macroglobulinemia
📧 Sign up to get email alerts when something new happens for Waldenström Macroglobulinemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-10-03Clinical Trial Update: B-Cell Hematologic Malignancy Vaccination Registry
A clinical trial update indicates that the B-cell hematologic malignancy vaccination registry (NCT02298816) sponsored by Wake Forest Univers…
-
CLINICAL_TRIALS withdrawal · 2016-07-14Clinical Trial Update: Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies [Phase 2]
A Phase 2 clinical trial evaluating single or double donor umbilical cord blood transplant for high-risk hematologic malignancies has been w…
-
CLINICAL_TRIALS withdrawal · 2015-03-06Clinical Trial Update: S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia [Phase 2]
A Phase 2 SWOG trial evaluating observation or combination chemotherapy with bortezomib, thalidomide, and rituximab followed by two autologo…
-
CLINICAL_TRIALS withdrawal · 2013-01-08Clinical Trial Update: Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia [Phase 2]
A Phase 2 clinical trial of alemtuzumab for Waldenström's macroglobulinemia has been withdrawn.